Physiological Saline Global Market Report 2024

Physiological saline, often referred to as saline solution, is a sterile mixture containing a specific concentration of sodium chloride (salt) dissolved in water, mirroring the salt concentration found in the human body. It is employed for numerous medical purposes, including wound cleaning, intravenous infusion, medication dilution, and irrigation of body cavities during surgeries. Physiological saline is essential for maintaining hydration, electrolyte balance, and cellular function, making it a vital component in healthcare settings for patient care, medical procedures, and emergency treatments.

The primary types of physiological saline are normal saline, hypertonic saline, and hypotonic saline. Normal saline, also known as isotonic saline, contains 0.9% sodium chloride in water, closely matching the salt concentration in human blood. The uses of physiological saline span acute health conditions, chronic diseases, skin abrasions, burns, and more, and it is utilized by various end users such as hospitals, clinics, recovery centers, and other healthcare facilities.

The physiological saline market research report is one of a series of new reports that provides physiological saline market statistics, including physiological saline industry global market size, regional shares, competitors with a physiological saline market share, detailed physiological saline market segments, market trends and opportunities, and any further data you may need to thrive in the physiological saline industry. This physiological saline market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The physiological saline market size has grown strongly in recent years. It will grow from $5.99 billion in 2023 to $6.52 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the adoption of saline solutions in emergency medical services, increasing demand for saline in surgical procedures, a stronger focus on infection control, regulatory standards mandating the use of sterile saline solutions, and heightened awareness of the importance of hydration.

The physiological saline market size is expected to see strong growth in the next few years. It will grow to $9.16 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The projected growth period is expected to be driven by the integration of saline solutions in diagnostic procedures, an expanding geriatric population, the growth of home healthcare services, consumer preference for natural and non-toxic products, and global efforts to enhance access to essential healthcare supplies. Key trends in this forecast period include the development of specialized formulations of physiological saline, the incorporation of physiological saline into telemedicine platforms, the creation of novel formulations, the adoption of advanced packaging solutions, and technological innovations enhancing the safety and efficacy of saline solutions.

The increase in surgical procedures is anticipated to drive the growth of the physiological saline market in the future. Surgical procedures, performed by trained healthcare professionals, are medical interventions that diagnose, treat, or cure diseases, injuries, or abnormalities through invasive techniques involving incisions, excisions, sutures, or other manipulations. Factors such as advancements in surgical techniques, greater access to healthcare services, and an aging population with higher medical needs contribute to the rise in surgical procedures, which in turn boosts the demand for surgical interventions. Physiological saline is utilized in surgeries to clean wounds, hydrate tissues, and act as an irrigation medium. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based professional body for board-certified aesthetic plastic surgeons, reported an approximately 11.2% increase in procedures performed by plastic surgeons in 2022, with over 14.9 million surgical and 18.8 million non-surgical procedures conducted worldwide, representing a 41.3% rise over the last four years. Thus, the increase in surgical procedures is fueling the growth of the physiological saline market.

Leading companies in the physiological saline market are creating innovative products, such as heparin sodium in sodium chloride injection, to gain a competitive advantage. Heparin sodium in sodium chloride injection is a sterile solution that combines heparin sodium, an anticoagulant, with sodium chloride, and is used intravenously to prevent blood clotting during medical procedures or in patients at risk of thrombosis. For instance, in April 2021, Fresenius Kabi, a Germany-based healthcare company, launched two new versions of Heparin Sodium in Sodium Chloride Injection in the United States. These single-dose infusion products are available in two strengths, Heparin Sodium 1,000 USP units in a 0.9% sodium chloride 500-mL infusion bag and Heparin Sodium 2,000 USP units in a 0.9% sodium chloride 1,000-mL infusion bag. They are designed to act as anticoagulants to keep catheters open, reducing medication errors and ensuring patient safety.

In January 2023, Prestige Ameritech, a US-based manufacturer of disposable medical devices and automated machinery, acquired Anexa Biomedical for an undisclosed amount. This acquisition broadens Prestige’s product offerings to include sterile water and sterile saline, two products that have historically experienced shortages. Anexa Biomedical is a US-based manufacturer of saline solutions and sterile water.

Major companies operating in the physiological saline market are Cardinal Health Inc., Pfizer Inc., Fresenius Kabi AG, Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd, Grifols S.A., VWR International LLC., B Braun Medical Inc, Spectrum Chemical, Enzo Life Sciences Inc, The Stevens Company Limited, Boreal Science, HiMedia Laboratories, AdipoGen Life Sciences Inc, Thistle Scientific., G-Biosciences, Enzymes Pharmaceuticals, Labogens, and Hamdan Healthcare.

North America was the largest region in the physiological saline market in 2023. The regions covered in the physiological saline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the physiological saline market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The physiological saline market consists of sales of sterile saline solution, saline nasal spray, and saline eye drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.